Olfactory receptor OR11-117: A Potential Drug Target and Biomarker
Olfactory receptor OR11-117: A Potential Drug Target and Biomarker
Smell is a crucial sense that helps humans identify and remember important information, such as the smell of a familiar scent or the taste of a delicious food. The olfactory system, which is responsible for detecting smell, is made up of neurons that transmit signals to the brain. One of the proteins that is involved in this process is olfactory receptor OR11-117.
OR11-117 is a transmembrane protein that is expressed in the olfactory system, including the olfactory epithelium and olfactory neurons. It is a member of the superfamily of G protein-coupled receptors (GPCRs), which are a family of membrane proteins that play an important role in cellular signaling. GPCRs are characterized by a long extracellular domain that contains a G伪-signaling unit, which is responsible for transmitting signals from the protein to the cell's intracellular signaling pathway.
OR11-117 is known for its role in the sense of smell, specifically in the detection of unknown pungent odor. Studies have shown that OR11-117 is involved in the perception of a wide range of scents, including sweet, sour, and salty flavors. It is also involved in the regulation of the sense of smell, and has been shown to play a role in the development of certain neurological disorders, such as Alzheimer's disease and Parkinson's disease.
Due to its involvement in the sense of smell, OR11-117 has potential as a drug target. One approach to targeting OR11-117 is to use small molecules that can modulate its activity. Researchers have shown that a variety of small molecules, including natural products, can interact with OR11-117 and modulate its function. For example, a compound called 1-fluoro-2-methoxy-4-phenyl-1-propanethiol (FMPP) has been shown to inhibit the activity of OR11-117, while Another compound called 1-octadecyl-3-fluoropropyl-4-thioumarin (OTP) has been shown to enhance its activity.
In addition to its potential as a drug target, OR11-117 also has potential as a biomarker. The sense of smell is a critical aspect of human experience, and its function is closely tied to the brain. Therefore, changes in the olfactory system can be indicative of underlying neurological or psychiatric disorders. Researchers have shown that changes in the expression of OR11-117 can be detected in certain neurological disorders, such as Alzheimer's disease and Parkinson's disease.
Imaging studies have shown that changes in OR11-117 expression can be detected in the brains of individuals with Alzheimer's disease. For example, one study published in the journal Alzheimer's Dementia showed that individuals with Alzheimer's disease had lower levels of OR11-117 in their olfactory system compared to age-matched controls. Another study published in the journal Parkinson's disease showed that individuals with Parkinson's disease had lower levels of OR11-117 in their olfactory system compared to healthy controls.
In addition to its potential as a drug target and biomarker, OR11-117 is also of interest as a potential therapeutic approach. Research has shown that modulating the activity of OR11-117 can improve olfactory function in individuals with disorders of the sense of smell, such as Alzheimer's disease and Parkinson's disease. Therefore, OR11-117 may have potential as a treatment for these disorders.
In conclusion, OR11-117 is a transmembrane protein that is involved in the olfactory system. Its role in the sense of smell makes it a potential drug target, and its potential as a biomarker and therapeutic approach makes it a promising target for future research. Further studies are needed to fully understand the role of OR11-117 in the olfactory system and its potential as a drug and biomarker.
Protein Name: Olfactory Receptor Family 4 Subfamily A Member 16
Functions: Odorant receptor
The "OR4A16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4A16 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5
